Company Filing History:
Years Active: 2004-2006
Title: Ramesh B Bambal: Innovator in Cytochrome P450 Research
Introduction
Ramesh B Bambal is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biochemistry, particularly in the study of cytochrome P450 enzymes. With a total of 2 patents, his work has implications for drug metabolism and pharmacology.
Latest Patents
Ramesh's latest patents include innovative research on screening assays for inhibitors of human cytochrome P-450. One of his patents focuses on a fluorescein derivative as a substrate for cytochrome P450 enzymes. Another patent involves 7-alkoxycoumarins as CYP2C9 substrates and activity assays, utilizing coumarin derivatives as substrates for the cytochrome P450 enzyme.
Career Highlights
Ramesh B Bambal is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research in his field. His work has contributed to a better understanding of enzyme interactions and their applications in drug development.
Collaborations
Throughout his career, Ramesh has collaborated with esteemed colleagues, including Jacqueline Carol Bloomer and Richard Leonard Elliott. These collaborations have fostered a productive research environment and have led to significant advancements in their shared field of study.
Conclusion
Ramesh B Bambal's contributions to cytochrome P450 research highlight his innovative spirit and dedication to advancing biochemistry. His patents and collaborations reflect a commitment to improving drug metabolism understanding, which is crucial for the pharmaceutical industry.